GYKI-14451, formerly known as LY-178207, is a synthetic tripeptide inhibitor of thrombin with anti-atherosclerotic activity. References: Callas DD, Fareed J. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy. Thromb Res. 1995 Jun 1;78(5):457-60. PubMed PMID: 7544924.

纯度：≥98%

CAS：83861-29-4